357 related articles for article (PubMed ID: 14960261)
21. Collaborative study for the establishment of erythropoietin BRP batch 4.
Burns C; Bristow AF; Daas A; Costanzo A
Pharmeur Bio Sci Notes; 2015; 2015():246-53. PubMed ID: 26830170
[TBL] [Abstract][Full Text] [Related]
22. Collaborative study for the establishment of replacement batches of heparin low- molecular-mass for assay biological reference preparations.
Terao E; Daas A; Rautmann G; Buchheit KH
Pharmeur Bio Sci Notes; 2010 Oct; 2010(2):30-6. PubMed ID: 21144487
[TBL] [Abstract][Full Text] [Related]
23. Establishment of European pharmacopoeia Mycoplasma reference strains.
Milne C; Daas A
Pharmeuropa Bio; 2006 Nov; 2006(1):57-72. PubMed ID: 17270132
[TBL] [Abstract][Full Text] [Related]
24. Collaborative study for the establishment of tetanus vaccine (adsorbed) Third International Standard and European Pharmacopoeia Biological Reference Preparation batch no. 2.
Sesardic D; Winsnes R; Rigsby P; Gaines-Das R
Pharmeuropa Spec Issue Biol; 2001 Aug; 2001(1):45-72. PubMed ID: 11705100
[TBL] [Abstract][Full Text] [Related]
25. Collaborative study for the establishment of erythropoietin BRP batch 5.
Ferguson J; Burns CJ; Regourd E; Costanzo A
Pharmeur Bio Sci Notes; 2019; 2019():27-33. PubMed ID: 30880683
[TBL] [Abstract][Full Text] [Related]
26. Validation and standardisation of nucleic acid amplification technology (NAT) assays for the detection of viral contamination of blood and blood products.
Saldanha J
J Clin Virol; 2001 Jan; 20(1-2):7-13. PubMed ID: 11163577
[TBL] [Abstract][Full Text] [Related]
27. Production and characterisation of a candidate hyper-immune serum for the replacement of the Bordetella pertussis mouse antiserum Biological Reference Preparation.
Morgeaux S; Bornstein N; Mourton-Gilles C; Chagnaud P; Charbonneau J; Maurin J; Daas A; Variot P; Behr-Gross ME
Pharmeur Bio Sci Notes; 2020; 2020():141-160. PubMed ID: 32788037
[TBL] [Abstract][Full Text] [Related]
28. Multicenter evaluation of a commercial multiplex polymerase chain reaction test for screening plasma donations for parvovirus B19 DNA and hepatitis A virus RNA.
Koppelman MH; Cuijpers HT; Wessberg S; Valkeajärvi A; Pichl L; Schottstedt V; Saldanha J
Transfusion; 2012 Jul; 52(7):1498-508. PubMed ID: 22587637
[TBL] [Abstract][Full Text] [Related]
29. New BRP for human plasma calibrated for coagulation factors V, VIII, XI and XIII - collaborative study for establishment of batches 1 and 2.
Bayer P; Daas A; Milne C
Pharmeur Bio Sci Notes; 2011 Nov; 2011(2):16-25. PubMed ID: 22225765
[TBL] [Abstract][Full Text] [Related]
30. Establishment of the first World Health Organization International Standard for human parvovirus B19 DNA nucleic acid amplification techniques.
Saldanha J; Lelie N; Yu MW; Heath A;
Vox Sang; 2002 Jan; 82(1):24-31. PubMed ID: 11856464
[TBL] [Abstract][Full Text] [Related]
31. A significantly lower potency observed for the 3rd WHO International Standard for Parvovirus B19V DNA with the cobas TaqScreen DPX test.
Pisani G; Cristiano K; Fabi S; Simeoni M; Marino F; Gaggioli A
Vox Sang; 2016 Aug; 111(2):115-9. PubMed ID: 27149002
[TBL] [Abstract][Full Text] [Related]
32. Collaborative study for the establishment of erythropoietin BRP batch 3.
Behr-Gross ME; Daas A; Burns C; Bristow AF
Pharmeuropa Bio; 2007 Dec; 2007(1):49-66. PubMed ID: 18413137
[TBL] [Abstract][Full Text] [Related]
33. Collaborative study to establish a new biological reference preparation for prekallikrein activator.
Longstaff C; Behr-Gross ME; Daas A; Lackner F
Pharmeuropa Bio; 2005 Sep; 2005(1):1-12. PubMed ID: 16336933
[TBL] [Abstract][Full Text] [Related]
34. Collaborative study to establish a World Health Organization International genotype panel for parvovirus B19 DNA nucleic acid amplification technology (NAT)-based assays.
Baylis SA; Ma L; Padley DJ; Heath AB; Yu MW;
Vox Sang; 2012 Apr; 102(3):204-11. PubMed ID: 21988191
[TBL] [Abstract][Full Text] [Related]
35. Establishment of the human albumin for electrophoresis Ph. Eur. BRP batches 3 and 4.
Behr-Gross ME; Daas A; Eulig-Wien A; Christians S
Pharmeur Bio Sci Notes; 2015; 2015():181-9. PubMed ID: 26830166
[TBL] [Abstract][Full Text] [Related]
36. Standardization of nucleic acid amplification technique (NAT)-based assays for different genotypes of parvovirus B19: a meeting summary.
Baylis SA
Vox Sang; 2008 Jan; 94(1):74-80. PubMed ID: 18171331
[TBL] [Abstract][Full Text] [Related]
37. Establishment of replacement batches for prekallikrein activator in albumin biological reference preparation.
Lackner F; Daas A; Terao E; Behr-Gross ME
Pharmeuropa Bio; 2008 Dec; 2008(1):1-6. PubMed ID: 19220976
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of an automated high-volume extraction method for viral nucleic acids in comparison to a manual procedure with preceding enrichment.
Hourfar MK; Schmidt M; Seifried E; Roth WK
Vox Sang; 2005 Aug; 89(2):71-6. PubMed ID: 16101686
[TBL] [Abstract][Full Text] [Related]
39. Establishment of Ph. Eur. Bordetella pertussis mouse antiserum Biological Reference Preparation batches 2, 3 and 4.
Morgeaux S; Chagnaud P; Variot P; Le Tallec D; Behr-Gross ME
Pharmeur Bio Sci Notes; 2020; 2020():161-202. PubMed ID: 32788038
[TBL] [Abstract][Full Text] [Related]
40. Calibration of the Ph. Eur. human coagulation Factor VIII concentrate BRP batch 5.
Raut S; Costanzo A; Daas A; Buchheit KH
Pharmeur Bio Sci Notes; 2017; 2017():1-11. PubMed ID: 28279252
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
